Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY:CVS)

69.40 -0.78 (-1.11%)
Streaming Delayed Price Updated: 11:49 AM EDT, Apr 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
54 55 Next >
Unpacking the Latest Options Trading Trends in CVS Health
Via Benzinga
CVS Stock is Nearing a 52-Week Low, Better Buy Than Walgreens?
CVS stock is making its way above Walgreens as a potential watchlist addition. Fundamentals and price targets see the stock making a comeback this year. 
Via MarketBeat
Walmart Pulls Plug On Health Centers, Telehealth; Respite For TDOC?
Walmart is shutting down its health centers and virtual care offering, continuing a broader shakeup in telehealth. WMT stock is near a buy point. 
Via Investor's Business Daily
AbbVie Outlook: Why Humira Biosimilars Won't Undo A Projected $73 Billion In Sales
The company is projected to bring in increasing sales through at least 2029. 
Via Investor's Business Daily
DoorDash: 5 Compelling Reasons to Buy the Dip
DoorDash Inc. (NASDAQ: DASH) is the leading restaurant and food delivery service in the United States - should you buy the dip? 
Via MarketBeat
Topics Death
Exposures Death
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages. 
Via Benzinga
Topics Stocks
Exposures US Equities
Is This Beaten-Down Dividend Stock a Buy?
The company has one major strength: It offers essential services. 
Via The Motley Fool
3 Value Stocks to Buy on the Dip: April 2024
With the tech sector fallout leading to some red ink, here are the value stocks to buy on the dip for astute investors. 
Via InvestorPlace
Arthritis Patients - Cigna's Evernorth To Offer Humira Biosimilar At No Out-of-Pocket Cost
Evernorth Health Services' initiative to offer Humira biosimilar with $0 out-of-pocket costs for patients. Save an average of $3,500 yearly. 
Via Benzinga
5 High-Yielding Oversold Stocks with Bullish Ratings
Investors have favored defensive sectors in the short term, and oversold high-yielding names might become more in play as tensions rise and the market pulls in. 
Via MarketBeat
Topics Economy
Exposures Interest Rates
7 blue chip stocks to Buy on the Dip: April 2024
Each of these seven blue-chip stocks to buy on the dip offer high-quality at a more-than-reasonable price. 
Via InvestorPlace
3 Absurdly Cheap Stocks to Buy and Hold for Years
These stocks all deserve to be trading at far higher prices, and it may not be too long before they start to rally. 
Via The Motley Fool
Looking Into CVS Health's Recent Short Interest
Via Benzinga
Analyst Ratings For CVS Health
Via Benzinga
CVS Health Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
Put $5,000 in These 7 Blue-Chip Stocks Today
If you’re looking for reliability, jump into safer blue-chip stocks. They’re not all exciting, but they have proven to be ultra-reliable. 
Via InvestorPlace
Beat the Dow Jones With This Cash-Gushing Dividend Stock
The change in interest rate expectations has created a big opportunity for patient investors. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
The Smartest Dividend Stocks to Buy With $400 Right Now
These stocks all offer growing and generous dividends. 
Via The Motley Fool
The Bad News Heading Into AbbVie's First-Quarter Earnings Report
AbbVie is working against numerous biosimilar versions of Humira. But one has "stepped up dramatically." 
Via Investor's Business Daily
Freeport-McMoRan, AppLovin And A Major Healthcare Stock On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management said AppLovin Corporation (NASDAQ: APP) is the number one performing 
Via Benzinga
3 Defensive Stocks to Buy for Increased Volatility in April
Fortify your portfolio against increased market volatility with three defensive stocks that perform no matter what the economic climate. 
Via InvestorPlace
3 Weight-Loss ETFs to Profit From the Obesity Drug Boom
Leverage Oprah's shift to prescription weight solutions with Weight-Loss ETFs, targeting companies leading in obesity treatment. 
Via InvestorPlace
Topics ETFs
See How Florida's Much Awaited Medicaid Re-Procurement Awards Impact Centene, Humana, Molina
Florida announces Medicaid contract awards to Centene, Elevance Health, and Humana, sidelining UnitedHealth, CVS Health, and Molina. Details on MMA and LTC services for over 3.4 million Floridians... 
Via Benzinga
Girl Power Portfolio: 3 High-Potential Stocks With Women CEOs to Buy Now
Stocks with women CEOs often outperform their counterparts. These three companies are great examples of that. 
Via InvestorPlace
7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape
Although the market may be grumbling over certain issues, concerned investors can trust these healthcare stocks to deliver the goods. 
Via InvestorPlace
CVS Health's Zero-Cost Coverage Paves Way For OTC Birth Control Access
CVS Health expands coverage to include the first OTC birth control pill in the U.S., offering accessible contraception without prescription costs. Learn about this pivotal shift in reproductive... 
Via Benzinga
Market Rally Under Pressure; Tesla, Humana In Focus: Weekly Review
The indexes and leading stocks are generally holding key levels. 
Via Investor's Business Daily
Why Shares of UnitedHealth Group, CVS Health, and Humana Fell Today
The federal agency that administers the Medicare program just approved a 3.7% payment rate increase. Here's why that's bad for insurance stocks. 
Via The Motley Fool
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss. 
Via Benzinga
Israel Kills Top Iranian General – Oil Rises – Not Great For Stock Market's No Inflation Story
To gain an edge, this is what you need to know today. Raise Hedges It is time to raise hedges.  As full disclosure, a signal was given to The Arora Report members. 
Via Benzinga
Topics Economy
Exposures Interest Rates
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
54 55 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.